Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search


ICPbio Has Further $2.152 Million Debt Reduction

ICPbio Has Further $2.152 Million Debt Reduction

Statement made by Dr Earl Stevens, Managing Director, ICP Biotechnology Limited

ICP Biotechnology is pleased to announce that it has placed a Convertible Note (equity) with DEC International (NZ) Limited for $1.5 million.

Under the terms of this Convertible Note DEC will have the right to convert to ordinary shares of ICP Biotechnology Limited post 31 December 2006 and the final date for conversion is the 31st July 2008.

In addition, DEC has subscribed for 2,608,000 ordinary ICP shares, paying $652,000 which equates to a share price of 25 cents per share.

These transactions reduce the original debt to DEC from $2.752 million to $600,000, repayable July 2007 although they have the option to convert this to ordinary ICP shares post 31 December 2006, should they choose to.

At the Special Meeting held 5th May 2006, the shareholders approved the issue of Preference Shares for $4.5 million in replacement of a term loan, as set out in the notice of meeting.

This overall conversion of debt to equity has now reduced ICPbio’s term debt by over $6.6 million and strengthened its balance sheet considerably. The overall term debt for the company is now approximately half of what it was at the beginning of May.

This comes on top of the just announced NZ$18,175,540 disposal of the old APH Group ‘The Escarpments’ project which will settle on or before the 23 June 2006.

ICPbio is one of New Zealand's longest established biotechnology companies. It manufactures and markets products for use in animal reproduction, animal health care and the fine biochemicals field. ICPbio's vision is set on becoming a leading global manufacturer of quality biological products for the biotechnology, animal and human pharmaceutical industries. Nearly 100% of its products are exported, primarily to North America and Europe, with increasing amounts to Asia and South America.


© Scoop Media

Business Headlines | Sci-Tech Headlines


Onetai Station: Overseas Investment Office Puts Ceol & Muir On Notice

The Overseas Investment Office (OIO) has issued a formal warning to Ceol & Muir and its owners, Argentinian brothers Rafael and Federico Grozovsky, for failing to provide complete and accurate information when they applied to buy Onetai Station in 2013. More>>


Tomorrow, The UN: Feds President Takes Reins At World Farming Body

Federated Farmers president Dr William Rolleston has been appointed acting president of the World Farmers’ Organisation (WFO) at a meeting in Geneva overnight. More>>


I Sing The Highway Electric: Charge Net NZ To Connect New Zealand

BMW is turning Middle Earth electric after today announcing a substantial contribution to the charging network Charge Net NZ. This landmark partnership will enable Kiwis to drive their electric vehicles (EVs) right across New Zealand through the installation of a fast charging highway stretching from Kaitaia to Invercargill. More>>


Watch This Space: Mahia Rocket Lab Launch Site Officially Opened

Economic Development Minster Steven Joyce today opened New Zealand’s first orbital launch site, Rocket Lab Launch Complex 1, on the Mahia Peninsula on the North Island’s east coast. More>>


Marketing Rocks!
Ig Nobel Award Winners Assess The Personality Of Rocks

A Massey University marketing lecturer has received the 2016 Ig Nobel Prize for economics for a research project that asked university students to describe the “brand personalities” of three rocks. More>>


Nurofen Promotion: Reckitt Benckiser To Plead Guilty To Misleading Ads

Reckitt Benckiser (New Zealand) intends to plead guilty to charges of misleading consumers over the way it promoted a range of Nurofen products, the Commerce Commission says. More>>


Get More From Scoop

Search Scoop  
Powered by Vodafone
NZ independent news